Tag:
Encysive
Latest Headlines
Latest Headlines
Pfizer snags Encysive in $195M buyout
Pfizer has demonstrated once again just how interested it is in biotech with its $195
FDA stands firms on need for Thelin trial
The FDA has handed Encysive its fourth--that's right, fourth--dose of bad news for Thelin, a pulmonary arterial hypertension treatment. Encysive received its
